TSWM
GSK icon

Tyler-Stone Wealth Management’s GSK GSK Stock Holding History

Tyler-Stone Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-443
Closed -$24K – 874
2022
Q1 		$24K Sell
443
-29
-6% -$1.57K 0.01% 446
2021
Q4 		$26K Buy
+472
New +$24.6K 0.01% 461

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Tyler-Stone Wealth Management's GSK Position: Q2 2022 in Review

Tyler-Stone Wealth Management sold out of GSK (GSK) in Q2 2022, closing a stake of 443 shares — an estimated $24K sold.

Tyler-Stone Wealth Management first reported a position in GSK in Q4 2021 and held it in 2 quarters. The position peaked at $26K in Q4 2021. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Tyler-Stone Wealth Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 443 GSK shares in Q2 2022, an estimated $24K.
  • Tyler-Stone Wealth Management first reported a position in GSK in Q4 2021 and held it in 2 quarters.
  • Tyler-Stone Wealth Management's GSK position peaked at $26K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.